Robot Walker for Elderly People in Public Spaces

Elderly people with walking difficulties are often intimidated by busy public places. This led an EU research project to develop a robot walker to guide them around shopping centres, museums and other public buildings, thus enhancing their autonomy. Shopping centres, airports, museums and hospitals are the kind of complex and confusing environments where elderly people on the verge of cognitive decline could have difficulties walking around without help. The walking frames they may currently use do not have the flexibility to help them navigate in often-crowded places.

This led researchers on the DALI project to develop a robotic cognitive walker (c-Walker) that can be taken to, or picked up at, the place to be visited, gently guiding the person around the building safely. The device takes corrective actions when the user comes across the type of busy area, obstacle or incident they want to avoid.

"The c-Walker is aimed at providing physical and cognitive support to older adults. It can give them confidence in public environments," explained Luigi Palopoli, professor at Italy's Trento University who coordinated DALI (Devices for Assisted Living). "The device is full of hi-tech solutions, but the user is not necessarily aware of them. She or he comes into contact with a ‘standard’ walker, with a few additions such as the display or bracelets and does not need any kind of computer literacy. The robot simply guides them so that they have a nice, safe experience."

Programming the robot before setting off
Shopping is recommended as a useful way for elderly people to exercise and is viewed as an important activity for prolonging their autonomous mobility. It also provides them with good opportunities to interact socially. For these reasons, shopping centres were considered by the DALI project to be a typical environment an elderly person would ideally visit. Picking up the c-Walker at the entrance, the elderly shopper selects the profile most suited to them on its simple touch-screen and the shops to visit. The c-Walker then recommends the best course to the user and guides them using visual, acoustic and haptic (tactile) interfaces.

The c-Walker uses different solutions (RFID tags, invisible QR codes, and cameras) to localise itself in the environment. Furthermore, it can connect with remote sensors, such as surveillance cameras, and with other c-Walkers deployed in the environment to gain remote knowledge of the presence of anomalies, crowded spaces or hazards. The device is equipped with brakes and motorised wheels. Haptic armbands tell users when and how to turn. They can also call for assistance if necessary.

DALI has been very much a user-driven project. The scientists spoke with focus groups of over 50 elderly people in Spain and the UK who explained their mobility needs so that features helping them could be incorporated into the robot. The c-Walker was later tested at residential care homes in Ciudad Real in Spain and Trento in Italy. Feedback from these trials was used to design a more advanced prototype.

By basing the design on software rather than expensive mechatronic components, the DALI consortium has been able to bring unit cost down from tens of thousands of euros to around EUR 2 000 per device.

Stepping out through social networks
DALI, funded with EUR 3 million from FP7, ended last October. But now there is a new three-and-a-half year project, ACANTO, which is developing the c-Walker further. ACANTO, receiving EUR 4.2 million from Horizon 2020, aims to bring c-Walker users together in social networks. "This will give them more incentive to go places," said Prof Palopoli. "While in DALI we focused on the single user, in ACANTO we are thinking of groups of users who can do things together, such as visit a museum."

The consortium believes that, by spinning off a company to market the device, or attracting investment from a major technological manufacturer, c-Walkers could be in common use by 2020.

For further information, please visit:
http://www.ict-dali.eu/dali/

© European Union, 1995-2015, CORDIS.
CORDIS is the European Commission's primary public repository and portal to disseminate information on all EU-funded research projects and their results in the broadest sense.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...